Abstract Activation of the transcription factor NF-jB is a highly regulated multi-level process. The critical step during activation is the release from its inhibitor IjB, which as any other protein is under the direct influence of translation regulation. In this review, we summarize in detail the current understanding of the impact of translational regulation on NF-jB activation. We illustrate a newly developed mechanism of eIF2a kinase-mediated IjB depletion and subsequent NF-jB activation. We also show that the classical NF-jB activation pathways occur simultaneously with, and are complemented by, translational down regulation of the inhibitor molecule IjB, the importance of one or the other being shifted in accordance with the type and magnitude of the stressing agent or stimuli.
NF-jB in cells is due to binding through the RHD to a member from the family of proteins called inhibitor of NFjB (IjB). IjB family consists of IjBa, IjBb, IjBe, IjBc, BCL-3, and the two NF-jB precursors p100 and p105 [12, 13] . IjBa and IjBb achieve the cytoplasmic localization by masking the nuclear localization sequence (NLS) of amino acids on the NF-jB p65 subunit [14] [15] [16] . Failure to mask the NLS of the p65 subunit in addition to the existence of a nuclear export sequence (NES) on IjBa and p65, results in the constant shuttling of IjBa:p65:p50 complexes between the cytoplasm and nucleus. On the other hand, IjBb:p65:p50 complexes are restricted to the extra nuclear compartment, this phenomena adding to the complexity of NF-jB regulation.
The role of kinases in regulation of NF-jB activation
After removing IjB, a second level of regulation is conferred mainly by stimulus-induced phosphorylation of NFjB [17] . A protein kinase A (PKA) phosphorylation site was identified on both p65 and c-Rel at Ser 276, located 25 amino acids from the NLS, inside the Rel homology domain (RHD) [18] . Over-expression of PKA leads to a higher DNA-binding activity of NF-jB. This is mainly due to the fact that phosphorylated Ser 276 inhibits intermolecular association with inhibitors, thus facilitating nuclearization and DNA binding [17, 19] . The same phosphorylation also promotes interaction with coactivator CREB binding protein (CBP/p300) [18] . A similar mechanism of NF-jB activation was identified during tumor necrosis factor a (TNFa) stimulation when p65 phosphorylation occurred at Ser 529 mediated by casein kinase II (CKII) [20, 21] . Also during TNFa stimulation another activating phosphorylation occurs at Ser 536 by none other than IKK [22] . It is worthy to note that the same catalytic activity of IKK is required for IjB phosphorylation followed by ubiquitination and NF-jB activation by direct phosphorylation, fact that adds to the complexity of IKK mediated NF-jB activation [23] . The activity of stimulated NF-jB is down regulated by a feedback pathway through the newly synthesized IjBa, one of the first genes activated by NF-jB. The re-synthesized IjBa enters the nucleus, binds to NF-jB and exports it to the cytosol, thus inhibiting its functionality [24, 25] .
The classical NF-jB activation mechanism
Upon extra-or intracellular stimulation the IjBs are phosphorylated by an IjB kinase (IKK), ubiquitin targeted and undergo proteosomal degradation thus automatically exposing the NLS necessary for NF-jB nuclear localization [26, 27] . IKK is a 700 kDa protein complex consisting of two catalytic subunits (IKKa and IKKb) and a regulatory subunit (IKKc or NEMO-NF-jB essential modulator) [28] [29] [30] . Activation of the catalytic subunits takes place by phosphorylation followed by intra-and intermolecular transautophosphorylation releasing their kinase domains. A host of NF-jB inducers have been recognized so far, they consist of but are not limited to proinflamatory cytokines (TNFa, IL-1, etc.), double-stranded RNA (dsRNA), viruses and a variety of cell stressors like ultraviolet light (UV), reactive oxygen species (ROS), and genotoxic agents [7, 31] . Some of NF-jB activators, such as cytokines, achieve activation through the classical activation mechanism (Fig. 1) , while others like UV, ROS, heat shock, and hypoxia regulate NF-jB through much more branched and complex cellular pathways [32] [33] [34] [35] . The common feature of these general inducers is that they cause translation inhibition as a defense cellular response through their noxious effects.
The impact of translation initiation on NF-jB activation
An entirely different approach to NF-jB activation is provided by translational regulation via the eukaryotic initiation factor 2 (eIF2). During the initiation step of translation, eIF2 forms a complex with GTP and MettRNA forming a ternary complex, which associated with the small ribosomal unit contributes to the selection of the start codon. The release from the ribosome is achieved at the expense of hydrolization of GTP to GDP. In order to restart the initiation cycle the guanine exchange factor eIF2B refreshes the eIF2-GDP to eIF2-GTP [36] . The phosphorylation on Ser 51 of the a subunit of eIF2 (eIF2a) stabilizes the eIF2-GDP-eIF2B initiation complex preventing GDP-GTP exchange, thus halting the translational initiation process [37, 38] . The eIF2a phosphorylation inhibits initiation of protein synthesis at a general level, allowing only the selective translation of some proteins that are required for mounting a stress response [39, 40] .
Key players in translational regulation are a host of serine-threonine kinases that can phosphorylate the Ser 51 of eIF2a. Four eIF2a kinases (EIF2AKs) have been identified. While each of the EIF2AKs has its own specific inducers, some stimulus such as UV and hypoxia also activate one or more of the kinases (Fig. 2) .
EIF2AK1, known as the heme-regulated inhibitor kinase (HRI), is a critical component during erythroid maturation that regulates the stoichiometric ratio of hemoglobin components, i.e., a-globin, b-globin, and heme [41] . Two separate heme binding sites were identified in HRI [42] . HRI is activated by heme deficiency in multi-stages through series of auto-phosphorylations [43] . The phosphorylation of HRI first stabilizes its monomer that lacks eIF2a kinase activity, but has first heme-binding site occupied. Further phosphorylation of HRI induces the dimerization and confers heme sensitivity [44] . During high heme concentrations, heme binds to the second binding site inhibiting HRI kinase activity thus allowing for protein and implicitly hemoglobin translation [45] . In the situation of insufficient heme accumulation the second heme-binding site remains unoccupied, which leads to the induction of HRI kinase activity and inhibition of translation by eIF2a phosphorylation [46] . While heme deficiency leads to activation of NF-jB, there is no direct evidence yet to show that the translation inhibition is involved in the activation of signaling pathways. Besides heme deficiency, other NF-jB activator, such as arsenite-induced oxidative stress and heat shock were also found to activate HRI [47] .
EIF2AK2, known as the interferon-induced doublestranded (ds) RNA-dependent protein kinase (PKR), plays a critical role in anti-viral defense [48] . The binding of the dsRNA exposes an ATP-binding site inducing dimerization and subsequent auto-phosphorylation leading to an active form of PKR [49] [50] [51] . A variety of stimuli, like growth factors and cytokines, activate PKR independently of dsRNA through PKR-associated activator proteins [52, 53] . Initially, PKR was suggested to directly phosphorylate IjB [54] . However, the hypothesis was challenged by results showing that kinase inactivated PKR is still capable of activating NF-jB [55] . Furthermore, co-immunoprecipitation analysis Fig. 1 The classical NF-jB activation pathway. Stimulus induced IKK phosphorylates IjB inducing its degradation. Free NF-jB translocates to the nucleus and binds to the target DNA, while its transactivation efficiency and ability to recruit other activators is further regulated by different kinases. IjB provides feedback inhibition through expulsion of NF-jB from the nucleus. The graphical representation of the molecular network was generated through the use of Ingenuity Pathways Analysis (Ingenuity Ò Systems). All lines are supported by at least one reference from the literature or from information of canonical pathways stored in the Ingenuity Pathways Knowledge Base Fig. 2 The eIF2 kinase regulated signaling pathways. A number of stimuli achieve eIF2a phosphorylation through the four known eIF2a kinases. The graphical representation of the molecular network was generated through the use of Pathway Studio 6 (Ariadne Genomics Ò ). All lines are supported by at least one reference from previously published literature stored in the Pathway Studio database demonstrated that PKR forms a complex with IKK independent of its ability of activation of NF-jB [55, 56] . Based on these findings, it was proposed that PKR binds to the IKK complex or acts upstream facilitating IKK to phosphorylate IjBa at serines 32 and 36 [55] [56] [57] [58] . Conversely, it has also been reported by others that PKR mutants that are unable to activate NF-jB still preserve their ability to co-immunoprecipitate with IKK [56] . While the roles of PKR and its catalytic activity in NF-jB activation remain controversial [55] [56] [57] [58] , several PKR activators, such as dsRNA and interferon c (IFNc) have been shown to induce NF-jB activation. Regardless of PKRs' inability to activate NF-jB independently of its kinase function, activated PKR does nevertheless phosphorylate eIF2a thus inhibiting global translation and potentially can decrease IjB synthesis.
EIF2AK3, also known as the PKR like endoplasmic reticulum (ER) related kinase (PERK), is an ER membrane localized kinase [59] [60] [61] . Its inactive monomer state is stabilized by an ER chaperone immunoglobulin (Ig) heavy chain binding protein (BiP). Under ER-stress, BiP releases PERK, which undergoes dimerization, trans-phosphorylation and sequentially activation [60] [61] [62] [63] . Outside or inside perturbations negatively affect protein-folding process in ER resulting in an accumulation of malfolded proteins, which triggers the unfolded protein response (UPR). While UPR transcriptionally activates the expression of ER chaperone to facilitate the folding process, it translationally inhibits general protein synthesis through phosphorylating eIF2a to reduce the accumulation of newly synthesized proteins in ER [64] . The converging point between the accumulation of unfolded proteins and global translation inhibition by eIF2a phosphorylation was determined to be PERK [59, 65] . The PERK-mediated eIF2a phosphorylation and translation inhibition was shown to be directly involved in ER-stress-mediated NF-jB activation upon various stimuli, such as hypoxia, UV, and thapsigargin [33, 34, [66] [67] [68] [69] .
EIF2AK4 is also known as the amino acid starvation dependent general control of amino acid biosynthesis kinase (GCN2) [70, 71] . It is an amino acid abundance controlled eIF2a kinase, which is activated during amino acid starvation. Its specific role is to halt protein translation while activating the translation of factors that are needed in amino acid synthesis [61, 72] . The activation mechanism involves a histidyl-tRNA synthase (HisRS) homologous sequence, where the excess of uncharged tRNAs bind during amino acid deprivation [73] . A C-terminal RNA binding region is also required for its dimerization, activation, and association with ribosome [74, 75] . The GCN2-mediated eIF2a phosphorylation and translation inhibition was shown to be directly involved in amino acid starvation induced NF-jB activation [66] . Besides nutritional stresses, the HisRS similar sequence also allows for activation by other stresses, such as UV and proteosome inhibition [71, 72] . While there is no evidence yet to show that GCN2 is directly involved in NF-jB activation upon proteosome inhibition, it has been demonstrated that GCN2 mediates UV-induced NF-jB activation [76] .
Besides eIF2a another initiation factor was recently also found to regulate NF-jB. This is the eukaryotic initiation factor 4E (eIF4E), which facilitates translation by binding to the 5 0 cap structure of the mRNA. Although for now the studies fall short of providing any details for the activation mechanism, they offer other possible alternatives to the classical NF-jB activation pathway [77] .
Regulation of IjB turnover
NF-jB is stranded in the cytoplasm bound by its inhibitor protein IjB. Even though both IjBa and IjBb are able to inhibit NF-jB, it is IjBa that bears the major role in regulating its activation [78] . NF-jB is a transcription factor that has a fast response time in order to react promptly to cellular stress. In order to achieve this fast activation, the IjB levels are tightly and rapidly regulated [79] . While activation of receptor signaling cascade, such as TNFa and interleukin-1 (IL-1), often leads to phosphorylation, ubiquitination, and proteolysis of IjB, the more general cellular stimulus, such as UV and hypoxia, also possess the ability to induce translational inhibition of IjB synthesis.
IjB degradation occurs through two mechanisms, i.e., a signal-dependent and signal-independent (basal degradation) process [80] . IjB turnover is tightly linked to its structural domains. The centrally located ankyrin repeats are necessary for NF-jB binding and the two terminal regions are implicated in the degradation of IjB. The N-terminal sequence contains two IKK phosphorylation sites Ser 32 and 36 [81] [82] [83] [84] and two ubiquitination sites Lys 21 and 22 [85, 86] . The phosphorylation and ubiquitination of these sites promote IjB degradation in the 26S proteosome. The C-terminal region contains a PEST domain (Pro, Glu, Asp, Ser, and Thr rich regions), which is associated in general with high turnover proteins [87] . The PEST site in addition to multiple casein kinase II (CKII) phosphorylation sites on the C-terminal region are needed for both signal-induced degradation [84, 88, 89] and basal turnover of IjB [17, 82, 90, 91] .
The rate of degradation of IjB is also very much influenced by its association with NF-jB. Free IjB has a 30-40 min half-life, but the NF-jB associated one has a fivefold longer degradation time [92] [93] [94] [95] . Free IjB constitutes only a 15% fraction of the total cellular IjB [92] , and is a weak substrate for IKK phosphorylation [96] . The basal turnover of free IjB requires the CKII phosphorylation sites while the signal-dependent degradation is induced by IKK phosphorylation. For the NF-jB associated IjB, the basal turnover is also regulated by CKII phosphorylation, while the signal-induced degradation is regulated by both CKII and IKK phosphorylation [80, 95, [97] [98] [99] (Table 1) .
While IKK and CKII regulate the removal rate of IjB, the EIF2AKs determine the synthetic rate of IjB. The phosphorylation of eIF2a by EIF2AK leads to the inhibition of global protein synthesis, including IjB. Since IjB has a relatively high basal turnover rate [79] , the inhibition of new IjB synthesis results in a rapid depletion of IjB thus shifting the dynamic balance from NF-jB associated IjB toward free NF-jB and IjB (Fig. 3) .
Targeting NF-jB for therapeutic development NF-jB plays an important role in regulation of the process of innate and adaptive immune responses. Its ability to activate transcription of genes encoding cytokines (e.g., TNFa, IL-1, IL-2, and IL-6), chemokines, adhesion molecules (e.g., ICAM, VCAM, and E-selectin), inducible enzymes (e.g., iNOS and COX-2), and antimicrobial peptides (b defensine) gives it a central role in the overall process of immune response [78] . NF-jB also regulates genes outside the immune system presumably having an anti-apoptotic effect that would give an opportunity to the cell to repair DNA damage. Deregulation of these genes may lead to many diseases, such as cancer, atherosclerosis, arthritis, AIDS, etc. [3] . NF-jB has been a target for the development of therapeutics for many diseases [100] . Since eIF2a phosphorylation also impacts NF-jB activation, compounds that affect eIF2a phosphorylation through the aforementioned kinases will be potential therapeutics for treatment of various diseases. Indeed, several ER-stress inducing drugs are already in the spotlight for their ability to induce apoptosis in malignant cells. The chemotherapeutic agents doxorubicin and cisplatin, although known to mainly target DNA, were also shown to induce ER-stress and activate PERK [101] [102] [103] [104] . Interferon and TNF-a are both antiviral proteins that have been used in combination with chemo-and radiation therapy and that possess the ability to activate PKR [105, 106] . In addition, the potential for successful use of proteasome inhibitors for cancer treatment may be granted by the ability of these compounds to induce apoptosis through the blocking of protein degradation, which implicitly leads to ER-stress. The antimultiple myeloma drug Velcade (PS-341), for example, which is a proteasome inhibitor, inhibits IjB degradation. In fact, Velcade was also shown to disrupt protein folding in the ER resulting in ER-stress [107] [108] [109] . In summary, elucidating the role of EIF2AK in mediation of NF-jB activation may lead us to a better understanding of the mechanisms of current NF-jB targeting drugs and development of new therapeutics to treat diseases related to deregulation of NF-jB. 
